Matches in Nanopublications for { ?s <http://purl.org/dc/terms/description> ?o ?g. }
- NP31896.RAiAl6HpNbRdwTvhBpbadccNmrjCzL8vYrrcq1i6rFWV8130_assertion description "[Repeat oral dose toxicity studies of melamine in rats and monkeys.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31896.RAiAl6HpNbRdwTvhBpbadccNmrjCzL8vYrrcq1i6rFWV8130_provenance.
- NP31897.RAkG8iAHm3omb0YLu4PpfzbbwOdn7rLc3J9jnYYoNbgVY130_assertion description "[Repeat oral dose toxicity studies of melamine in rats and monkeys.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31897.RAkG8iAHm3omb0YLu4PpfzbbwOdn7rLc3J9jnYYoNbgVY130_provenance.
- NP31898.RAn3VFYTN_KeQWPaQFMHJG0ACioq6dneRc1CmvE0-Iqq0130_assertion description "[Repeat oral dose toxicity studies of melamine in rats and monkeys.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31898.RAn3VFYTN_KeQWPaQFMHJG0ACioq6dneRc1CmvE0-Iqq0130_provenance.
- NP31894.RAGRMZCky7Jv9G54R_W793GJcESfBZZf1_712P9KaIZOU130_assertion description "[Repeat oral dose toxicity studies of melamine in rats and monkeys.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31894.RAGRMZCky7Jv9G54R_W793GJcESfBZZf1_712P9KaIZOU130_provenance.
- NP31895.RA-MV4Es0W6g46Od1CDDspYt3O67IUQ0O9e7Q5LATEuhA130_assertion description "[Repeat oral dose toxicity studies of melamine in rats and monkeys.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31895.RA-MV4Es0W6g46Od1CDDspYt3O67IUQ0O9e7Q5LATEuhA130_provenance.
- assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP381641.RAXasEdkJrX9MZTKKk0Kxnrjqvw0gHovS0rhTNTQJau-A130_assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381641.RAXasEdkJrX9MZTKKk0Kxnrjqvw0gHovS0rhTNTQJau-A130_provenance.
- NP381642.RAv2uWAdbX8Krwq5l-0yjmBTOIWCdd703c_ALlnKWWW-E130_assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381642.RAv2uWAdbX8Krwq5l-0yjmBTOIWCdd703c_ALlnKWWW-E130_provenance.
- NP217223.RA0P3pLf6wMG9nC5EyCKWQP_yy-MslZXdzcvM74HyibC8130_assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217223.RA0P3pLf6wMG9nC5EyCKWQP_yy-MslZXdzcvM74HyibC8130_provenance.
- NP637355.RA2DXzWlvXMzHZcAi4dHrx6rV76EDNs0_mv-R9nDktQX8130_assertion description "[Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands such as fatty acids and rosiglitazone increased functional cell surface LRP by 1.5-2.0-fold in primary human adipocytes and in the SW872 human liposarcoma cell line as assessed by activated alpha(2)-macroglobulin binding and degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637355.RA2DXzWlvXMzHZcAi4dHrx6rV76EDNs0_mv-R9nDktQX8130_provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP122882.RAT_Rr92zs0_dExuwx3YsrrfJBxj0FQQVCMeCippeODBo130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122882.RAT_Rr92zs0_dExuwx3YsrrfJBxj0FQQVCMeCippeODBo130_provenance.
- NP130177.RAQYzSULBzpyraknvnOhKZhRacUxGHUF5AKNF_3D8MgEk130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130177.RAQYzSULBzpyraknvnOhKZhRacUxGHUF5AKNF_3D8MgEk130_provenance.
- NP130206.RAZnIKc_d5ldQdyNdbieL9ownf2Bu6sdq3ZzY3BNsbrBY130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130206.RAZnIKc_d5ldQdyNdbieL9ownf2Bu6sdq3ZzY3BNsbrBY130_provenance.
- NP130261.RAYCEY9bAtZbT2rwvuICZR7uuE9N6pW-C94Vfx7bmPoz4130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130261.RAYCEY9bAtZbT2rwvuICZR7uuE9N6pW-C94Vfx7bmPoz4130_provenance.
- NP130283.RAZAhH10Scayuq9T_juX5_529jy0l119AtNctEXOHfJPM130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130283.RAZAhH10Scayuq9T_juX5_529jy0l119AtNctEXOHfJPM130_provenance.
- NP130310.RAfv5PzU9lnMWYcK9RpWGkosqmfW9sXuPEXZDE2U1bD04130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130310.RAfv5PzU9lnMWYcK9RpWGkosqmfW9sXuPEXZDE2U1bD04130_provenance.
- NP130340.RAa0UpP16oKKuJ119d5uC-rhRMG9Q-DILiFFsWXqLdvxA130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130340.RAa0UpP16oKKuJ119d5uC-rhRMG9Q-DILiFFsWXqLdvxA130_provenance.
- NP130374.RAQX7HRBDB8KQ6CIaQ4_1MU_RSrBcYO5kf5Wy3tAXLQS4130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130374.RAQX7HRBDB8KQ6CIaQ4_1MU_RSrBcYO5kf5Wy3tAXLQS4130_provenance.
- NP131484.RAVOycZ5yz0GurucqNMQxIy9JsMi50Hmcye-at6lvMjBc130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131484.RAVOycZ5yz0GurucqNMQxIy9JsMi50Hmcye-at6lvMjBc130_provenance.
- NP131487.RARyhQIku8hLHIeA5wlfMARrOiMOp7uBfBHuvjLRzA11g130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131487.RARyhQIku8hLHIeA5wlfMARrOiMOp7uBfBHuvjLRzA11g130_provenance.
- NP132835.RAcgB--wwSm0gwXkOR70iv9EyLs-mHqIH3udHuKELxo64130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132835.RAcgB--wwSm0gwXkOR70iv9EyLs-mHqIH3udHuKELxo64130_provenance.
- NP147215.RAfPRDz0gyvLMhFpc3dSgwQbSD6rCybwP-eQaOkbSKw0A130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147215.RAfPRDz0gyvLMhFpc3dSgwQbSD6rCybwP-eQaOkbSKw0A130_provenance.
- NP148855.RAWU3kdTcNC1KTOYY967g3JyzJpxgi4ISC7rrOBZvhanc130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148855.RAWU3kdTcNC1KTOYY967g3JyzJpxgi4ISC7rrOBZvhanc130_provenance.
- NP148876.RAZgql0mTVdGRRdts5mLXxa1AX5TYavwmYobsz5DcyIVw130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148876.RAZgql0mTVdGRRdts5mLXxa1AX5TYavwmYobsz5DcyIVw130_provenance.
- NP148964.RAZOxDXrTHqhcVYuAVvGInFHPq5H6oekyRnU7pey9twrA130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148964.RAZOxDXrTHqhcVYuAVvGInFHPq5H6oekyRnU7pey9twrA130_provenance.
- NP148972.RAbQrjZz59KodJuWqNMH0hO73ASvniMN5W_MkVT2KkkH8130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148972.RAbQrjZz59KodJuWqNMH0hO73ASvniMN5W_MkVT2KkkH8130_provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP109495.RAqIqV9VxjvF8utWD5hMQNJH00oZt3qKAhrmxXirqiy-s130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109495.RAqIqV9VxjvF8utWD5hMQNJH00oZt3qKAhrmxXirqiy-s130_provenance.
- NP109537.RApCwZekmIXu8DcBgeMHsPHAYoDsV04fc-4CpYTPo_rpA130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109537.RApCwZekmIXu8DcBgeMHsPHAYoDsV04fc-4CpYTPo_rpA130_provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP92658.RAgCpv6JabcLfZJtTAtMKu-DRGLV3ICtGgVVvoPThtbtg130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92658.RAgCpv6JabcLfZJtTAtMKu-DRGLV3ICtGgVVvoPThtbtg130_provenance.
- NP130159.RAqe3gARO46YSzIBlE8Jpw7UHEMF19Pyp9759RxgCjjTI130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130159.RAqe3gARO46YSzIBlE8Jpw7UHEMF19Pyp9759RxgCjjTI130_provenance.
- NP130214.RAjt5QSWSbgpqfEyoQ-3ygbeOzyPN0aHFnhd5phGhvJPM130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130214.RAjt5QSWSbgpqfEyoQ-3ygbeOzyPN0aHFnhd5phGhvJPM130_provenance.
- NP130233.RAkxk5ezUuPk5tUyGPnHflUV8C-Bglfg-CE85R8rIYbDI130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130233.RAkxk5ezUuPk5tUyGPnHflUV8C-Bglfg-CE85R8rIYbDI130_provenance.
- NP130234.RAosGyXPGhPGBoCC_Vo40NJIa6FxBqFc-wnaNciMiUS7I130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130234.RAosGyXPGhPGBoCC_Vo40NJIa6FxBqFc-wnaNciMiUS7I130_provenance.
- NP130299.RAlXcE8H7aOLNwj2gcmG7tANtx9Da0xi4wpV8haHIN5Io130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130299.RAlXcE8H7aOLNwj2gcmG7tANtx9Da0xi4wpV8haHIN5Io130_provenance.
- NP130312.RAsHLfFmz-W0XDhnWbXRs3OXvCt4j056O-eUVJIIFXpVU130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130312.RAsHLfFmz-W0XDhnWbXRs3OXvCt4j056O-eUVJIIFXpVU130_provenance.
- NP130341.RAsex8lsVmndBFEnm2f0YQeRHcLP6dvQlJ3k4xLNbl-Y0130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130341.RAsex8lsVmndBFEnm2f0YQeRHcLP6dvQlJ3k4xLNbl-Y0130_provenance.
- NP130350.RAl8xQnZs-DwiqMCuKsROHpa1iPPp2J0H_nYVcQ1FlX-A130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130350.RAl8xQnZs-DwiqMCuKsROHpa1iPPp2J0H_nYVcQ1FlX-A130_provenance.
- NP130351.RAq0FECxvnF3KJXrmq3WE52IHsBX-nTaoSVq_bDz5rcA8130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130351.RAq0FECxvnF3KJXrmq3WE52IHsBX-nTaoSVq_bDz5rcA8130_provenance.
- NP130510.RAuOabPE6C9HhqlQIS6xf-QzPRDZeyIpIZD8-GqxJ3Yo0130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130510.RAuOabPE6C9HhqlQIS6xf-QzPRDZeyIpIZD8-GqxJ3Yo0130_provenance.
- NP130511.RAihdhwMApxq1YJMpAxSJ9LZd_WYHtSyV38zZEH_aOc6g130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130511.RAihdhwMApxq1YJMpAxSJ9LZd_WYHtSyV38zZEH_aOc6g130_provenance.
- NP131483.RAiTNxF1xB8fVMMkmYSnX_oKxlnIvi_RfVZH4_Zos5pj0130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131483.RAiTNxF1xB8fVMMkmYSnX_oKxlnIvi_RfVZH4_Zos5pj0130_provenance.
- NP131488.RAsuQzyZqkCVLiS3MX_lycZ8T6FC0kdMAz9z8jl6xide8130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131488.RAsuQzyZqkCVLiS3MX_lycZ8T6FC0kdMAz9z8jl6xide8130_provenance.
- NP131489.RAue43AJRa3JkQv2c_3uliPpa9jZPlG6T5H31254VwLi4130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131489.RAue43AJRa3JkQv2c_3uliPpa9jZPlG6T5H31254VwLi4130_provenance.
- NP131496.RAqgr9v9gXRhW_vC_4GS4bGBMSLkq_H_Va0WWKC5DAy6g130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131496.RAqgr9v9gXRhW_vC_4GS4bGBMSLkq_H_Va0WWKC5DAy6g130_provenance.
- NP148839.RAtmDA-JfCMP1qFx_KG_W2Vz2kyR9cLXbcV-jmGK37ZK4130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148839.RAtmDA-JfCMP1qFx_KG_W2Vz2kyR9cLXbcV-jmGK37ZK4130_provenance.
- NP148842.RArXNRHVOt2kjeUO_bkhmrxwWli1Jz_ODlNrd8gzaJ8AY130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148842.RArXNRHVOt2kjeUO_bkhmrxwWli1Jz_ODlNrd8gzaJ8AY130_provenance.
- NP148877.RAsZzbU5cjeceVFOC3rc5cEes-JZgmSASl2ggHlbkmzAk130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148877.RAsZzbU5cjeceVFOC3rc5cEes-JZgmSASl2ggHlbkmzAk130_provenance.
- NP148954.RAs3LaTctm_ZFJVk88EXFMRkV32HspDWbLx9wwHYsCKeQ130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148954.RAs3LaTctm_ZFJVk88EXFMRkV32HspDWbLx9wwHYsCKeQ130_provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.